Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Generation Bio Co GBIO

Generation Bio Co. is a biotechnology company. The Company is innovating non-viral genetic medicines to provide durable, redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The Company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet... see more

Recent & Breaking News (NDAQ:GBIO)

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

GlobeNewswire 3 days ago

Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire April 2, 2024

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire March 6, 2024

Generation Bio to Present at the 2024 TD Cowen Health Care Conference

GlobeNewswire February 27, 2024

Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 3, 2024

Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms

GlobeNewswire November 29, 2023

Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results

GlobeNewswire November 9, 2023

Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform

GlobeNewswire October 26, 2023

Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel "Immune-Quiet" DNA

GlobeNewswire October 18, 2023

Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit

GlobeNewswire September 19, 2023

Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference 

GlobeNewswire August 3, 2023

Generation Bio Reports Second Quarter 2023 Financial Results

GlobeNewswire August 2, 2023

Generation Bio to Present at the 2023 Jefferies Healthcare Conference

GlobeNewswire May 31, 2023

Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results

GlobeNewswire May 10, 2023

Generation Bio to Present at the JMP Securities Life Sciences Conference

GlobeNewswire May 9, 2023

Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference 

GlobeNewswire April 11, 2023

Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer

GlobeNewswire April 5, 2023

Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines

GlobeNewswire March 23, 2023

Generation Bio to Participate in the BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines

GlobeNewswire March 21, 2023

Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference 

GlobeNewswire February 27, 2023